Kevin Kinsella Overview

  • Investor Type
  • Angel
  • Investments
  • 3
  • Portfolio
  • 1
  • Exits
  • 2
Exits

Kevin Kinsella General Information

Description

Mr. Kevin Kinsella is a Co-Founder of Avalon Ventures. He is the Founder of Avalon Bioventures. He serves as a Board Member at Eikonizo Therapeutics. He serves as Board Member at Ankasa. He served as Board Member at Avelas Biosciences. He is a Board Member at Jnana Therapeutics. He co-founded HauteDecor and served as its Chairman. He was the Founding Chairman at Landmark Graphics. He has specialized in the formation, financing, and development of more than 100 early-stage companies, including Athena Neurosciences Onyx Pharmaceuticals, Sequana, Vertex Pharmaceuticals, Synaptics, Vocera Communications, Amira Pharmaceuticals, Cardeas Pharma and Juliet Marine Systems. Mr. Kinsella was the founding chairman of Athena Neurosciences, Aurora Biosciences, Landmark Graphics, NeoRx, Onyx Pharmaceuticals, Synaptics, Vertex Pharmaceuticals, X-Ceptor, and Sequana Therapeutics. Prior to founding Avalon, Mr. Kinsella worked for Solar Turbines International (Caterpillar Tractor) where he was in charge of all international joint ventures, barter, and counter-trade. Previously, he was an advisor to the Peruvian government in National Nutrition Planning, ran a technology exchange program between the U.S. and Latin America based in Mexico City and taught algebra at the American High School in Beirut, Lebanon. He was also a guest op-ed columnist for the Boston Herald American. Mr. Kinsella is a graduate of the Massachusetts Institute of Technology ("MIT") with a Bachelor of Science degree in management, with minors in electrical engineering and political science. He holds a Master of Arts degree in international relations from the Johns Hopkins School of Advanced International Studies and conducted post-graduate work in political economy on a Rotary International Fellowship at the University of Stockholm, Sweden. Mr. Kinsella is a member of the Board of Directors of Cardeas Pharma. He also serves as Board Member at Juliet Marine Systems.

Contact Information

Primary Investor Type
Angel (individual)
Primary Office
  • 1134 Kline Street
  • La Jolla
  • San Diego, CA 92037
  • United States
+1 (858) 000-0000

Kevin Kinsella Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Eikonizo Therapeutics 16-May-2018 Seed Round 000 Drug Discovery Pre-Clinical Trials 00000 00000000
000000 01-Aug-2000 00000 00000 0000 Software Development Applications Generating Revenue 00000 00000000
000000000 10-Apr-2000 00000 (00000 000 Media and Information Services (B2B) Generating Revenue 00000 00000000
To view Kevin Kinsella’s complete investments history, request access »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kevin Kinsella Exits (2)

Company Name Exit Date Exit Type Exit Size
Covigo 30-Jul-2003 Merger/Acquisition
000000000 000000000 00000000
To view Kevin Kinsella’s complete exits history, request access »

Kevin Kinsella Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Kevin Kinsella Team (1)

Name Title Deals Funds Boards Office
Kevin Kinsella Angel Investor 00 0 0 San Diego, CA
To view Kevin Kinsella’s complete team members history, request access »

Kevin Kinsella Co-Investors (2)

Name With Exits Lead Partner Series Industry
Alzheimers Drug Discovery Foundation 1 0 Series chart Industry bar
F-Prime Capital 0 0 Series chart Industry bar
To view Kevin Kinsella’s complete co-investors history, request access »